Predicting Common Pathway Signatures Between DNA Methylation and Post Translational Modification in Type II Diabetes & Parkinson's Disease Using Heterogeneous Data Integration
Biswas, S.; Mitra, P.; Rao, K. S.
Show abstract
The complex diseases, namely, Type 2 Diabetes Mellitus (T2DM) and Parkinsons Disease (PD), are extensively studied due to their prevalence in a large population group. Between these two diseases, T2DM is denoted as the zero index disease in a patient, which may lead to PD in a more advanced clinical stage. Both of these diseases may occur due to abrupt DNA methylation of genes. Likewise, both diseases may occur in a patient due to protein misfolding. Our study proposes a novel framework for building two disease-specific heterogeneous networks by integrating different tissue-based transcriptomics, epigenetics, epistasis, and PPI-based topological information. We predict the missing links between the DNA methylation and Post-Translational Modification (PTMs) associated with protein aggregation. Next, we have predicted the common signature of the prevalence of linked patterns in both diseases, further validated by relevant biological evidence.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.